Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Vancouver biotech plans clinical trial of AI-development drug
The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...